Yahoo India Web Search

Search results

  1. Jun 24, 2024 · Biocon is an innovation led fully integrated biopharmaceutical company that develop affordable biosimilars, generic formulations & complex APIs.

  2. Jun 24, 2024 · We are enabling affordable access to lifesaving biosimilars worldwide. Driven by our collective vision of transforming healthcare and transforming patients’ lives, Biocon Biologics is making healthcare affordable and importantly accessible to millions of patients and their families across the world.

  3. Find all our corporate contact details for any enquiry or information related to our businesses or products or patient safety or investors...

  4. en.wikipedia.org › wiki › BioconBiocon - Wikipedia

    Biocon Limited is an Indian biopharmaceutical company based in Bangalore. It was founded by Kiran Mazumdar-Shaw in 1978. [4] The company manufactures generic active pharmaceutical ingredients (APIs) that are sold in approximately 120 countries, [5] including the United States and Europe. [4]

  5. Biocon Biologics Limited Biocon House, Semicon Park Electronics City, Phase – II, Hosur Road Bengaluru 560100, Karnataka, India T +91 80 6775 6775 E corporate.communications@biocon.com W www.bioconbiologics.com

  6. Mar 14, 2024 · Biocon Biologics Limited, a fully integrated global biosimilars company and a subsidiary of Biocon Limited (BSE code: 532523, NSE: BIOCON), today announced a long -term commercial collaboration with Eris Lifesciences to expand patient access to its portfolio of Metabolics, Oncology, and Critical Care products in India.

  7. Jun 24, 2024 · Biocon on Monday said its unit Biocon Biologics has received approval from the European Medicines Agency (EMA) to manufacture biosimilar Bevacizumab at its new facility at Bengaluru. This approval ...

  8. Biocon Biologics is today one of the frontrunners in the global biosimilars industry, working to provide patients access to affordable biologics and enable health equity worldwide. Driven by a Purpose to Address Unmet Needs for Affordable Biologics.

  9. A global biopharmaceutical company changing patients’ lives by finding new & affordable ways to treat diabetes, cancer & autoimmune diseases.

  10. Biocon Biologics Ltd on Monday announced that it has received approval from the European Medicines Agency (EMA) to manufacture biosimilar Bevacizumab at its new multi-product monoclonal antibodies ...